That is a made up moat, not a real one. The products are not groundbreaking because how easily replicated they are. I think people need to remember that the products are outsourced from Fonterra and Synlait. Anyone could come to them and order the exact same products.
There is no science behind the products. A2M’s claim is reliant on a condition called A1 intolerance existing, but in reality there has never been such a condition documented anywhere. Not even A2M itself know conclusively what the symptoms of A1 intolerance are, yet A2M is claiming to have a product to alleviate it.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)